Evidence map›Paper›PMID 23267098›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations.

Shizue Tani-ichi, Akihiro Shimba, Keisuke Wagatsuma, Hitoshi Miyachi, Satsuki Kitano, Kumiko Imai, Takahiro Hara, Koichi Ikuta

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Generation of effector CD4Stem cell reports · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. IL-7Rα on CD4Journal of neuroinflammation · 2024
    Article
  8. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  9. Review
  10. Advances in IL-7 Research on Tumour Therapy.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. A Beginner's Guide to T Cell Development.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shizue Tani-ichiLaboratory of Biological Protection, Department of Biological Responses and Reproductive Engineering Team, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan. staniich@virus.kyoto-u.ac.jp
Akihiro Shimba
Keisuke Wagatsuma
Hitoshi Miyachi
Satsuki Kitano
Kumiko Imai
Takahiro Hara
Koichi Ikuta
Response Biomedical (Canada) · CAKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-7 is a cytokine essential for T lymphocyte development and homeostasis. However, little is known about the roles of IL-7 receptor α-chain (IL-7Rα) in late stages of T-cell development. To address this question, we established IL-7Rα-floxed mice and crossed them with CD4-Cre transgenic mice. Resultant IL-7R conditional knockout (IL-7RcKO) mice exhibited marked reduction in CD8 single positive (SP) T cells, regulatory T cells (Tregs), and natural killer T (NKT) cells in thymus. The proportion and proliferation of both mature CD4SP and CD8SP thymocytes were decreased without affecting Runx expression. In addition, expression of the glucocorticoid-induced TNF receptor was reduced in CD4SP and CD8SP thymocytes, and expression of CD5 was decreased in CD8SP thymocytes. IL-7RcKO mice also showed impaired Treg and NKT cell proliferation and inhibition of NKT cell maturation. Bcl-2 expression was reduced in CD4SP and CD8SP thymocytes but not in Tregs and NKT cells, and introduction of a Bcl-2 transgene rescued frequency and CD5 expression of CD8SP thymocytes. Furthermore, IL-7RcKO mice exhibited greatly increased numbers of B cells and, to a lesser extent, γδ T and dendritic cells in thymus. Overall, this study demonstrates that IL-7Rα differentially controls development and maturation of thymocyte subpopulations in late developmental stages and suggests that IL-7R expression on αβ T cells suppresses development of other cell lineages in thymus.

Indexed as

AnimalsBromodeoxyuridineCell DifferentiationCore Binding Factor alpha SubunitsFlow CytometryInterleukin-7 Receptor alpha SubunitLymphocyte SubsetsMiceMice, KnockoutProto-Oncogene Proteins c-bcl-2Real-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionThymocytesBromodeoxyuridineCore Binding Factor alpha SubunitsInterleukin-7 Receptor alpha SubunitProto-Oncogene Proteins c-bcl-2

Identifiers

PMID23267098
PMCPMC3545802
OpenAlexW2117395313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.